Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Duodopa 20 mg/ml + 5 mg/ml intestinal gel

Active Ingredient:
levodopa , carbidopa monohydrate
Company:  
AbbVie Ltd See contact details
ATC code: 
N04BA02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Duodopa Best practice patient aftercare

{healthcare_pro_orange} For Healthcare Professionals
This short guide provides advice to healthcare professionals on the management of patients with advanced Parkinson’s disease who have started Duodopa therapy
{pdf_link}

Duodopa Critical Aspects of PEG-J Preparation Placement and Aftercare

{healthcare_pro_orange} For Healthcare Professionals
The information presented in these slides is provided as part of additional Risk Minimisation Program for Duodopa targeted to minimise: –Gastrointestinal (GI) events –Device-related risks –Procedure-related risks associated with the levodopa – carbidopa intestinal gel (LCIG) system
{pdf_link}

Duodopa Patient Pocket Guide

{healthcare_pro_orange} For Healthcare Professionals
This pocket guide provides a practical overview of the Duodopa system and potential complications related to the medication and its delivery system.
{pdf_link}

Duodopa PEG-J aftercare guideline

{healthcare_pro_orange} For Healthcare Professionals
This guide provides advice to healthcare professionals on how to minimise PEG-J tube related complications in patients receiving Duodopa therapy. It should be used in conjunction with any local guidance and the CADD-Legacy 1400 pump instruction manual.
{pdf_link}

Duodopa Safety, PEG-J insertion and aftercare, LCIG System Use and Pump Operations

{healthcare_pro_orange} For Healthcare Professionals
Important Additional Risk Minimisation Information for Healthcare Professionals Training for AbbVie Duodopa Specialists on LCIG System, PEG-J Placement, Aftercare and Minimisation of Procedure Complications

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

AbbVie Ltd
Company image
Address
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
Telephone
+44 (0)1628 561 092
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)1628 561 092
WWW
www.abbviemedinfo.com
WWW
www.abbvie.co.uk